Reuters logo
BRIEF-Novabay Pharmaceuticals sees FY 2017 revenue $19 million
March 23, 2017 / 8:59 PM / 9 months ago

BRIEF-Novabay Pharmaceuticals sees FY 2017 revenue $19 million

March 23 (Reuters) - Novabay Pharmaceuticals Inc

* Novabay Pharmaceuticals reports 2016 full year and fourth quarter financial results and provides 2017 financial guidance

* Q4 sales rose 149 percent to $4.1 million

* Q4 loss per share $0.11

* Sees FY 2017 revenue up 60 percent

* Sees FY 2017 revenue $19 million

* Novabay Pharmaceuticals Inc- Sees 2017 net loss of $6.2 million, excluding effect of non-cash gain on change in fair value of warrant liability

* Novabay Pharmaceuticals Inc- Sees 2017 cash burn of $3 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below